Published in Eur J Biochem on May 01, 2001
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging (2003) 2.05
Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci (2010) 1.02
NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol (2011) 0.96
Neuropeptide Y receptors: how to get subtype selectivity. Front Endocrinol (Lausanne) (2013) 0.94
Neuropeptide Y enhances olfactory mucosa responses to odorant in hungry rats. PLoS One (2012) 0.87
G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake. Proc Natl Acad Sci U S A (2010) 0.86
Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs. Br J Pharmacol (2003) 0.81
Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats. Am J Physiol Endocrinol Metab (2012) 0.79
Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line. Br J Pharmacol (2009) 0.79
Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig. Br J Pharmacol (2002) 0.79
Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation. Mol Metab (2015) 0.77
Neuropeptide Y receptors: a promising target for cancer imaging and therapy. Regen Biomater (2015) 0.77
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol (1994) 1.43
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Action of derivatives of mu-conotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. Biochemistry (1992) 1.39
ESAG 6 and 7 products of Trypanosoma brucei form a transferrin binding protein complex. Eur J Cell Biol (1994) 1.25
Palmitoylation alters protein activity: blockade of G(o) stimulation by GAP-43. EMBO J (1992) 1.13
A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg Med Chem Lett (1998) 1.07
Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci (2000) 1.07
Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. J Mol Biol (2001) 1.06
From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. J Med Chem (1998) 1.03
Epitope mapping of the Dermatophagoides pteronyssinus house dust mite major allergen Der p II using overlapping synthetic peptides. Mol Immunol (1991) 1.03
Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia (2011) 1.02
Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem (2001) 1.02
Comparison of the photochemical behavior of four different photoactivatable probes. J Pept Res (1997) 1.00
The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem (2000) 1.00
Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur J Biochem (2000) 0.99
Biosynthesis of peptide hormones derived from precursor sequences. Curr Med Chem (2004) 0.96
Evolutionary conservation of synaptosome-associated protein 25 kDa (SNAP-25) shown by Drosophila and Torpedo cDNA clones. J Biol Chem (1993) 0.96
Peptides as carrier for tumor diagnosis and treatment. Curr Med Chem Anticancer Agents (2001) 0.96
Strong evolutionary conservation of neuropeptide Y: sequences of chicken, goldfish, and Torpedo marmorata DNA clones. Proc Natl Acad Sci U S A (1992) 0.95
Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. Biochemistry (1997) 0.93
PYY3-36 as an anti-obesity drug target. Obes Rev (2005) 0.90
Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem Biophys Res Commun (1993) 0.89
Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol (1996) 0.89
Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation. J Pept Sci (1997) 0.89
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Mol Pharmacol (1996) 0.88
Radiometal targeted tumor diagnosis and therapy with peptide hormones. Curr Pharm Des (2008) 0.87
Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices. J Neurophysiol (2000) 0.85
Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline. Clin Exp Immunol (1993) 0.85
Origins of the many NPY-family receptors in mammals. Peptides (2001) 0.85
Evolution of the neuropeptide Y family and its receptors. Ann N Y Acad Sci (1998) 0.84
Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling. Regul Pept (2002) 0.83
Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland. Regul Pept (2001) 0.83
On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family. Biol Chem (1999) 0.82
[125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides (1997) 0.82
New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. Q J Nucl Med Mol Imaging (2007) 0.82
99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjug Chem (2001) 0.82
CGRP 27-37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay. Regul Pept (1999) 0.81
Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor. Regul Pept (1998) 0.81
Complex gene organization of synaptic protein SNAP-25 in Drosophila melanogaster. Gene (1997) 0.81
Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides (2001) 0.81
Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol (1992) 0.81
A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J Pept Sci (1997) 0.81
Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line. Peptides (2000) 0.80
Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res (1998) 0.80
Neuropeptide Y receptor subtype with unique properties cloned in the zebrafish: the zYa receptor. Brain Res Mol Brain Res (1999) 0.80
The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors. Eur J Pharmacol (1996) 0.80
Molecular characterization of the ligand-receptor interaction of neuropeptide Y. Curr Med Chem (1999) 0.80
Probing of the neuropeptide Y-Y1-receptors interaction with anti-receptor antibodies. Eur J Biochem (1998) 0.80
Biophysical methods to study ligand-receptor interactions of neuropeptide Y. Biopolymers (2001) 0.79
Role of a hydrophobic pocket of the human Y1 neuropeptide Y receptor in ligand binding. Mol Cell Endocrinol (1995) 0.79
Peptide binding and photo-crosslinking to detergent solubilized and to reconstituted transporter associated with antigen processing (TAP). FEBS Lett (1997) 0.79
On the synthesis of orexin A: a novel one-step procedure to obtain peptides with two intramolecular disulphide bonds. J Pept Sci (2000) 0.79
Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. FEBS Lett (1996) 0.78
Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes. Neuropeptides (2013) 0.78
Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue. Neuropharmacology (1995) 0.78
Characterisation of G-protein-coupled receptors by antibodies. Curr Med Chem (2000) 0.78
Modulatory effect of two novel CGRP receptor antagonists on nasal vasodilatatory responses to exogenous CGRP, capsaicin, bradykinin and histamine in anaesthetised pigs. Regul Pept (2001) 0.78
Optimization of capillary electrophoresis of mixtures of basic peptides and comparison with HPLC. Anal Chem (1993) 0.77
Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes. Gen Comp Endocrinol (2012) 0.77
Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors. Biochem Pharmacol (2000) 0.77
Studies of the human, rat, and guinea pig Y4 receptors using neuropeptide Y analogues and two distinct radioligands. Peptides (2001) 0.77
A new approach to secondary structure evaluation: secondary structure prediction of porcine adenylate kinase and yeast guanylate kinase by CD spectroscopy of overlapping synthetic peptide segments. Biopolymers (1997) 0.77
Conformational and epitope mapping of herpes-simplex-virus type-1 thymidine kinase using synthetic peptide segments. Eur J Biochem (1991) 0.76
Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes. J Recept Signal Transduct Res (1997) 0.76
Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats. Regul Pept (2005) 0.76
Comparison of antibodies directed against receptor segments of NPY-receptors. J Recept Signal Transduct Res (1999) 0.76
Structure-activity relationships with neuropeptide Y analogues: a comparison of human Y1-, Y2- and rat Y2-like systems. Regul Pept (1998) 0.76
Neuropeptide Y-induced mast cell activation. Biochem Soc Trans (1994) 0.76
Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist. Regul Pept (1996) 0.76
Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br J Pharmacol (1996) 0.75
The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. Behav Brain Res (2012) 0.75
TP5 triggers signal transduction involving mitogen activated protein kinases in monocytes. J Recept Signal Transduct Res (1999) 0.75
The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor. Eur J Biochem (1997) 0.75
Fluorescence-labeled octapeptides as substrates for histone deacetylase. Bioconjug Chem (2001) 0.75
Anchor-linked intermediates in peptide amide synthesis are caused by dimeric anchors on the solid supports. J Pept Sci (1997) 0.75
Molecular characterization of the human neuropeptide Y Y2-receptor. Biochemistry (1999) 0.75
Peptides@mica: from affinity to adhesion mechanism. Phys Chem Chem Phys (2016) 0.75
Calcitonin-derived carrier peptides. Curr Pharm Des (2005) 0.75
Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists. Experientia (1994) 0.75
Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships. Biopolymers (1991) 0.75
Characterization of the cloned atlantic cod neuropeptide Y-Yb receptor: peptide-binding requirements distinct from known mammalian Y receptors. Gen Comp Endocrinol (1999) 0.75
Low potency inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by [Ala31]NPY, an L-alanine substituted analogue of neuropeptide Y. Neurosci Lett (1995) 0.75
Mapping of phosphorylation-dependent anti-tau monoclonal antibodies in immunoblots using human tau-constructs synthesized by native chemical ligation. Biochem Biophys Res Commun (2007) 0.75
Cleavage kinetics and anchor linked intermediates in solid phase peptide amide synthesis. Int J Pept Protein Res (1991) 0.75
Evaluation of the secondary structure of vaccinia-virus thymidine kinase by circular-dichroism spectroscopy of overlapping synthetic peptides. Eur J Biochem (1996) 0.75
Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5. Neuropeptides (2002) 0.75
Functional characterization of the in vitro folded human y(1) receptor in lipid environment. Protein Pept Lett (2010) 0.75